# Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer

> **NCT03601988** · PHASE3 · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 408 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **RADIATION:** Concurrent chemo-radiotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03601988
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-28
- **Primary completion:** 2020-07-28
- **Final completion:** 2022-07-28
- **Target enrollment:** 408 (ESTIMATED)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03601988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03601988, "Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03601988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*